Small vessel vasculitis History, classification, etiology, histopathology, clinic, diagnosis and treatment

Small-vessel vasculitis is a convenient descriptor for a wide range of diseases characterized by vascular inflammation of the venules, capillaries, and/or arterioles with pleomorphic clinical manifestations. The classical clinical phenotype is leukocytoclastic vasculitis with palpable purpura, but manifestations vary widely depending upon the organs involved. Histopathologic examination in leukocytoclastic vasculitis reveals angiocentric segmental inflammation, fibrinoid necrosis, and a neutrophilic infiltrate around the blood vessel walls with erythrocyte extravasation. The etiology of small-vessel vasculitis is unknown in many cases, but in others, drugs, post viral syndromes, malignancy, primary vasculitis such as microscopic polyarteritis, and connective tissue disorders are associated. The diagnosis of small-vessel vasculitis relies on a thorough history and physical examination, as well as relevant antibody testing including antinuclear antibody and antineutrophil cytoplasmic antibody, hepatitis B and C serologies, assessment of complement, immunoglobulins, blood count, serum creatinine, liver function tests, urinalysis, radiographic imaging, and biopsy. The treatment is based primarily on corticosteroid and immunosuppressive agents.

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. , 2010, Arthritis and rheumatism.

[2]  R. Falk,et al.  Nosology of primary vasculitis , 2007, Current opinion in rheumatology.

[3]  U. Maggiore,et al.  Outcome and prognostic factors during the course of primary small-vessel vasculitides. , 2006, The Journal of rheumatology.

[4]  R. Luqmani,et al.  Outcome in small-vessel systemic vasculitis. , 2006, The Journal of rheumatology.

[5]  A. I. Gamarra,et al.  Hitos históricos de las vasculitis de pequeños vasos , 2006 .

[6]  P. Chapman,et al.  The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. , 2006, Rheumatology.

[7]  R. Luqmani,et al.  Clinical and biological assessment in systemic necrotizing vasculitides. , 2006, Clinical and experimental rheumatology.

[8]  A. I. Gamarra,et al.  Análisis crítico de las clasificaciones de las vasculitis , 2006 .

[9]  C. Langford,et al.  Advances in the treatment of small vessel vasculitis. , 2006, Rheumatic diseases clinics of North America.

[10]  C. Stegeman Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis: is the glass half full or half empty? , 2005, The Journal of rheumatology.

[11]  G. Hoffman,et al.  Are There Different Forms of Life in the Antineutrophil Cytoplasmic Antibody Universe? , 2005, Annals of Internal Medicine.

[12]  Ying Zhang,et al.  Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. , 2005, Kidney international.

[13]  F. Spertini,et al.  Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis. , 2005, The Journal of rheumatology.

[14]  Jianwen Cai,et al.  Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic AntibodyAssociated Small-Vessel Vasculitis , 2005, Annals of Internal Medicine.

[15]  C. Kallenberg Churg-Strauss syndrome: just one disease entity? , 2005, Arthritis and rheumatism.

[16]  Laura Pavone,et al.  Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. , 2005, Arthritis and rheumatism.

[17]  David G I Scott,et al.  Epidemiology of systemic vasculitis , 2005, Current rheumatology reports.

[18]  J. Stone,et al.  Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies , 2005, Current opinion in rheumatology.

[19]  J. Savige,et al.  What do antineutrophil cytoplasmic antibodies (ANCA) tell us? , 2005, Best practice & research. Clinical rheumatology.

[20]  J. Stone,et al.  The antineutrophil cytoplasmic antibody-associated vasculitides. , 2004, The American journal of medicine.

[21]  I. Uthman Pharmacological therapy of vasculitis: an update. , 2004, Current opinion in pharmacology.

[22]  E. Popa,et al.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis , 2003, Clinical and experimental immunology.

[23]  E. Csernok Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. , 2003, Autoimmunity reviews.

[24]  J. Balow,et al.  New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney , 2003, Current opinion in nephrology and hypertension.

[25]  L. Guillevin,et al.  When should immunosuppressants be prescribed to treat systemic vasculitides? , 2003, Internal medicine.

[26]  C. Magro,et al.  Cutaneous vasculitis: a review , 2003, Journal of cutaneous pathology.

[27]  L. Kamesh,et al.  ANCA-positive vasculitis. , 2002, Journal of the American Society of Nephrology : JASN.

[28]  P. Leboit,et al.  Vasculitis: The true and the near-true. , 2002, The American Journal of dermatopathology.

[29]  E. Thervet,et al.  Henoch-Schönlein Purpura in adults: outcome and prognostic factors. , 2002, Journal of the American Society of Nephrology : JASN.

[30]  C. Kallenberg,et al.  New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. , 2002, Autoimmunity reviews.

[31]  E. Matteson Historical perspective of vasculitis: Polyarteritis nodosa and microscopic polyangiitis , 2002, Current rheumatology reports.

[32]  M. González-Gay,et al.  Epidemiology of the vasculitides. , 2001, Rheumatic diseases clinics of North America.

[33]  J. Llorca,et al.  Henoch-Schönlein Purpura in Children from Northwestern Spain: A 20-Year Epidemiologic and Clinical Study , 2001, Medicine.

[34]  J. Levy New aspects in the management of ANCA-positive vasculitis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  E. Matteson Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schönlein, Wegener, Churg and Strauss, Horton, Takayasu, Behçet, and Kawasaki. , 2000, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[36]  R. Gans,et al.  Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. , 2000, Kidney international.

[37]  R. Kettritz,et al.  Necrotizing small-vessel vasculitis confined to the uterine cervix. , 2000, Seminars in arthritis and rheumatism.

[38]  Lawrence E. Gibson,et al.  Erythema elevatum diutinum. , 2000, Clinics in dermatology.

[39]  C. Ferreli,et al.  Less common treatment in cutaneous vasculitis. , 1999, Clinics in dermatology.

[40]  N. Cassano,et al.  Immunosuppressive therapy in cutaneous vasculitis. , 1999, Clinics in dermatology.

[41]  G. Hautmann,et al.  The many faces of cutaneous vasculitis. , 1999, Clinics in dermatology.

[42]  L. Parish,et al.  Vasculitis: the historical development of the concept , 1999 .

[43]  T. Lotti,et al.  Proposal for a working classification of cutaneous vasculitis. , 1999, Clinics in dermatology.

[44]  C. Kallenberg,et al.  What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications. , 1999, Current opinion in nephrology and hypertension.

[45]  E. Hachulla,et al.  Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. , 1999, The American journal of medicine.

[46]  C. Franssen,et al.  Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti‐proteinase 3 and anti‐myeloperoxidase autoantibodies , 1998, Journal of internal medicine.

[47]  P Lesavre,et al.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. , 1998, Kidney international.

[48]  R. Falk,et al.  Small-vessel vasculitis. , 1997, The New England journal of medicine.

[49]  V. Rodríguez-Valverde,et al.  Clinical features and outcome of 95 patients with hypersensitivity vasculitis. , 1997, The American journal of medicine.

[50]  D. Fiorentino,et al.  Cutaneous vasculitis , 1996 .

[51]  T. Lotti,et al.  CUTANEOUS NECROTIZING VASCULITIS , 1996, International journal of dermatology.

[52]  E. R. Mcfadden,et al.  Hypocomplementemic Urticarial Vasculitis Syndrome: Clinical and Serologic Findings in 18 Patients , 1995, Medicine.

[53]  C. Kallenberg,et al.  Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. , 1994, Kidney international.

[54]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[55]  J. Callen Cutaneous vasculitis: Relationship to systemic disease and therapy , 1993 .

[56]  E. Egea,et al.  Análisis histórico de las Vasculitis, su clasificación y propuesta para su entendimiento , 1993 .

[57]  E. Csernok,et al.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects , 1993, Clinical and experimental immunology.

[58]  D. Mehregan,et al.  Urticarial vasculitis: a histopathologic and clinical review of 72 cases. , 1992, Journal of the American Academy of Dermatology.

[59]  T. Carey,et al.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. , 1990, Annals of internal medicine.

[60]  T. The,et al.  Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre , 1990, The Lancet.

[61]  J. Hoidal,et al.  Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. , 1990, Blood.

[62]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[63]  J. Lüdemann,et al.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme , 1990, The Journal of experimental medicine.

[64]  C. Hack,et al.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. , 1989, The Journal of clinical investigation.

[65]  C. Kallenberg,et al.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies. , 1989, Archives of internal medicine.

[66]  M. Arnaout,et al.  Wegener9s granulomatosis autoantigen is a novel neutrophil serine proteinase [see comments] , 1989 .

[67]  M. Arnaout,et al.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. , 1989, Blood.

[68]  J. Jorizzo,et al.  Neutrophilic vascular reactions. , 1988, Journal of the American Academy of Dermatology.

[69]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[70]  J. Callen CUTANEOUS VASCULITIS AND ITS RELATIONSHIP TO SYSTEMIC DISEASE , 1987, Disease-a-month : DM.

[71]  K. Weismann,et al.  Erythema elevatum diutinum and pre-AIDS. , 1986, Acta dermato-venereologica.

[72]  E. Alexander,et al.  Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in connective tissue disease. , 1985, Arthritis and rheumatism.

[73]  T. H. The,et al.  AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.

[74]  W. Adam,et al.  Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. , 1984, Australian and New Zealand journal of medicine.

[75]  J. Callen,et al.  Cutaneous Leukocytoclastic Vasculitis: Clinical and Laboratory Features of 82 Patients Seen in Private Practice , 1984 .

[76]  W. Su,et al.  Lymphocytic vasculitis: is it a specific clinicopathologic entity? , 1984, Journal of cutaneous pathology.

[77]  J. Elias,et al.  Histologic studies of chronic idiopathic urticaria. , 1983, The Journal of allergy and clinical immunology.

[78]  J. E. Moran,et al.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? , 1982, British medical journal.

[79]  F. C. Mcduffie,et al.  Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. , 1982, Mayo Clinic proceedings.

[80]  F. Mullick,et al.  Drug related vasculitis. Clinicopathologic correlations in 30 patients. , 1979, Human pathology.

[81]  Soter Na,et al.  Cutaneous necrotizing venulitis. , 1979 .

[82]  B. Haynes,et al.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. , 1978, Annals of internal medicine.

[83]  J. Callen,et al.  CUTANEOUS ANGIITIS (VASCULITIS) , 1978, International journal of dermatology.

[84]  A. Fauci,et al.  ERYTHEMA ELEVATUM DIUTINUM: SKIN AND SYSTEMIC MANIFESTATIONS, IMMUNOLOGIC STUDIES, AND SUCCESSFUL TREATMENT WITH DAPSONE , 1977, Medicine.

[85]  Smiley Jd,et al.  Cutaneous necrotizing vasculitis and related disorders. , 1976 .

[86]  M. Mihm,et al.  Two distinct cellular patterns in cutaneous necrotizing angiitis. , 1976, The Journal of investigative dermatology.

[87]  T. Ryan,et al.  THE PROBLEMS OF CLASSIFICATION OF CUTANEOUS ANGIITIS WITH REFERENCE TO HISTOPATHOLOGY AND PATHOGENESIS , 1970 .

[88]  J. Churg,et al.  Wegener's granulomatosis: pathology and review of the literature. , 1954, A.M.A. archives of pathology.

[89]  P. Zeek Periarteritis nodosa and other forms of necrotizing angiitis. , 1953, The New England journal of medicine.

[90]  P. Zeek Periarteritis Nodosa: A Critical Review , 1952 .

[91]  J. Churg,et al.  Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. , 1951, The American journal of pathology.

[92]  Gouley Studies on periarteritis nodosa. III. The differentiation between the vascular lesions of periarteritis nodosa and of hypersensitivity , 1949 .

[93]  R PLATT,et al.  The kidney in periarteritis nodosa. , 1948, The Quarterly journal of medicine.

[94]  P. Zeek,et al.  Studies on periarteritis nodosa; the differentiation between the vascular lesions of periarteritis nodosa and of hypersensitivity. , 1948, The American journal of pathology.

[95]  F. Weidman,et al.  ERYTHEMA ELEVATUM DIUTINUM: ROLE OF STREPTOCOCCI, AND RELATIONSHIP TO OTHER RHEUMATIC DERMATOSES , 1929 .

[96]  Privatdozent Dr. Friedrich Wohlwill Über die nur mikroskopisch erkennbare Form der Periarteriitis nodosa , 1923, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[97]  W. Osler THE VISCERAL LESIONS OF PURPURA AND ALLIED CONDITIONS , 1914, British medical journal.

[98]  R. Willan On Cutaneous Diseases , 1845 .

[99]  M. Rodríguez,et al.  Vasculitis de vasos de pequeño calibre con afectación renopulmonar , 2009 .

[100]  M. López-Rodríguez,et al.  [Historical perspective on the classification of vasculitis]. , 2007, Actas dermo-sifiliograficas.

[101]  S. Hodes,et al.  Cutaneous Leukocytoclastic Vasculitis in a Patient with HIV , 2007 .

[102]  J. Brewer,et al.  HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS SYNDROME , 2006 .

[103]  L. Moreland Cutaneous leukocytoclastic vasculitis , 2004 .

[104]  W. Koldingsnes,et al.  Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. , 2003, The Journal of rheumatology.

[105]  A. Iglesias,et al.  Historia de las vasculitis , 2002 .

[106]  P. Merkel,et al.  Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. , 2000, Arthritis and rheumatism.

[107]  J. J. Wisnieski Urticarial vasculitis. , 2000, Current opinion in rheumatology.

[108]  W. Gross [Primary systemic vasculitis. I. General overview]. , 1999, Der Internist.

[109]  G. Hoffman,et al.  Antineutrophil cytoplasmic antibodies. , 1998, Arthritis and rheumatism.

[110]  R. Falk,et al.  Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. , 1996, Journal of the American Society of Nephrology : JASN.

[111]  C. Kallenberg,et al.  Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis , 1994, Annals of Internal Medicine.

[112]  W. Piette The differential diagnosis of purpura from a morphologic perspective. , 1994, Advances in dermatology.

[113]  J. Jorizzo Classification of vasculitis. , 1993, The Journal of investigative dermatology.

[114]  C J Michet,et al.  Epidemiology of vasculitis. , 1990, Rheumatic diseases clinics of North America.

[115]  J. Callen,et al.  Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. , 1990, Archives of dermatology.

[116]  Lie Jt Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. , 1989 .

[117]  E. Egea,et al.  Vasculitis linfomonocitica. Informe de nueve casos , 1987 .

[118]  J. Melski,et al.  Cutaneous necrotizing venulitis. , 1979, Cutis.

[119]  W. M. Sams,et al.  Hypocomplementemia with cutaneous vasculitis and arthritis: a new syndrome. , 1974, Archives of dermatology.

[120]  F. Wegener Über eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arterien systems und der Nieren , 1939 .